Back
Day Range
$20.37
$21.22
52-Week Range
$19.50
$34.13
Volume
353,111
50D / 200D Avg
$21.19
/
$25.08
Prev Close
$20.34
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 34.2 | 0.4 |
| P/B | 1.8 | 2.9 |
| ROE % | 5.1 | 3.7 |
| Net Margin % | 6.0 | 3.8 |
| Rev Growth 5Y % | 4.3 | 10.0 |
| D/E | 0.0 | 0.2 |
Key Takeaways
Revenue grew 4.32% annually over 5 years — modest growth
Debt/Equity of 0.04 — conservative balance sheet
Generating 59.63M in free cash flow
P/E of 34.18 — premium valuation
Cash machine — converts 325.12% of earnings into free cash flow
Capital efficient — spends only 1.21% of revenue on capex
Growth
Revenue Growth (5Y)
4.32%
Revenue (1Y)4.26%
Earnings (1Y)-8.32%
FCF Growth (3Y)-1.74%
Quality
Return on Equity
5.14%
ROIC4.12%
Net Margin6.03%
Op. Margin6.66%
Safety
Debt / Equity
0.04
Current Ratio0.96
Interest Coverage0.00
Valuation
P/E Ratio
34.18
P/B Ratio1.77
EV/EBITDA29.92
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 4.26% | Revenue Growth (3Y) | 4.38% |
| Earnings Growth (1Y) | -8.32% | Earnings Growth (3Y) | 9.80% |
| Revenue Growth (5Y) | 4.32% | Earnings Growth (5Y) | 33.10% |
| Profitability | |||
| Revenue (TTM) | 304.06M | Net Income (TTM) | 18.34M |
| ROE | 5.14% | ROA | 3.52% |
| Gross Margin | 64.74% | Operating Margin | 6.66% |
| Net Margin | 6.03% | Free Cash Flow (TTM) | 59.63M |
| ROIC | 4.12% | FCF Growth (3Y) | -1.74% |
| Safety | |||
| Debt / Equity | 0.04 | Current Ratio | 0.96 |
| Interest Coverage | 0.00 | Dividend Yield | 0.01% |
| Valuation | |||
| P/E Ratio | 34.18 | P/B Ratio | 1.77 |
| P/S Ratio | 2.06 | PEG Ratio | -4.98 |
| EV/EBITDA | 29.92 | Dividend Yield | 0.01% |
| Market Cap | 626.89M | Enterprise Value | 605.41M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 304.06M | 291.65M | 279.06M | 266.83M | 256.71M |
| Net Income | 18.34M | 20.01M | 15.21M | 12.09M | 5.85M |
| EPS (Diluted) | 0.61 | 0.66 | 0.50 | 0.39 | 0.18 |
| Gross Profit | 196.86M | 193.71M | 184.04M | 175.68M | 165.68M |
| Operating Income | 20.24M | 21.29M | 16.02M | 12.45M | 8.06M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 520.37M | 510.77M | 499.94M | 497.74M | 486.75M |
| Total Liabilities | 166.35M | 151.41M | 159.19M | 163.68M | 147.73M |
| Shareholders' Equity | 354.02M | 359.36M | 340.75M | 334.06M | 339.02M |
| Total Debt | 14.68M | 20.17M | 20.25M | 23.32M | 29.11M |
| Cash & Equivalents | 36.16M | 59.47M | 40.33M | 46.02M | 46.91M |
| Current Assets | 119.66M | 153.12M | 130.21M | 114.38M | 106.85M |
| Current Liabilities | 124.15M | 115.69M | 118.36M | 117.21M | 100.35M |